Inhibition of TBK1/IKKe mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing
Anastasia Piskopou, David W. Vredevoogd, Xiangjun Kong, Daniel S. Peeper, Maarten A. F. Altelaar, Kelly E. Stecker
This study shows that inhibiting TBK1/IKKe-mediated RIPK1 phosphorylation increases tumor sensitivity to immune cell killing by disrupting TNF signaling.
bioRxiv · May 20, 2025 · PreprintCell Biology